Get the Stockscreener App
2.64
0.38%
-0.010
After Hours:
2.64
X.T.L. Biopharmaceuticals Ltd. ADR Stock (XTLB) Forecast
The X.T.L. Biopharmaceuticals Ltd. ADR (XTLB) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $2.1907, representing a -17.02% decrease from the current price of $2.64. The highest analyst price target is $2.3808, and the lowest is $2.0006.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month XTLB Price Target
Average 1.6145
(-38.84% Downside)
Is X.T.L. Biopharmaceuticals Ltd. ADR (XTLB) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 52.04 | Neutral |
| STOCH(9,6) | 30.38 | Neutral |
| STOCHRSI(14) | 13.59 | Buy |
| MACD(12,26) | 0.0371 | Sell |
| ADX(14) | 28.23 | Buy |
| William %R | -48.57 | Neutral |
| CCI(14) | -171.16 | Sell |
Buy: 2
Sell: 2
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.6468
Sell
|
2.6357
Buy
|
| MA20 |
2.6184
Buy
|
2.6194
Buy
|
| MA50 |
2.6833
Sell
|
2.4186
Buy
|
| MA100 |
1.8126
Buy
|
2.0398
Buy
|
| MA200 |
1.3792
Buy
|
1.6828
Buy
|
Buy: 8
Sell: 2
Neutral: 0
Summary: Buy
According to our latest analysis, XTLB could be considered a Strong Buy, with 17 technical analysis indicators signaling 10 Buy signals, 4 signaling Sell signals and 3 Neutral signals. This might be a good time to open fresh positions on XTLB, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 52.04 indicates that XTLB is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 30.38 indicates that XTLB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 13.59 indicates that XTLB is oversold. This suggests that XTLB price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 28.23 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -171.16 indicates that XTLB is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term XTLB price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about X.T.L. Biopharmaceuticals Ltd. ADR financial reports and earnings history, X.T.L. Biopharmaceuticals Ltd. ADR (XTLB) stock could reach $2.7706 by 2030, $2.0587 by 2040 and $3.4995 by 2050. See the projected annual prices until 2050 of the X.T.L. Biopharmaceuticals Ltd. ADR stock below:
- X.T.L. Biopharmaceuticals Ltd. ADR (XTLB) is expected to reach an average price of $1.4173 in 2035, with a high prediction of $1.6072 and a low estimate of $1.3926. This indicates an $-46.31% rise from the last recorded price of $2.64.
- X.T.L. Biopharmaceuticals Ltd. ADR (XTLB) stock is projected to chart a bullish course in 2040, with an average price target of $1.9493, representing an $-26.16% surge from its current level. The forecast ranges from a conservative $1.8589 to a sky-high $2.0587.
- Our analysts predict X.T.L. Biopharmaceuticals Ltd. ADR (XTLB) to jump -13.37% by 2045, soaring from $2.1563 to an average price of $2.287, potentially reaching $2.4368. While $2.1563 is the low estimate, the potential upside is significant.
- X.T.L. Biopharmaceuticals Ltd. ADR (XTLB) stock is expected to climb by 2050, reaching an average of $2.9405, a $11.38% jump from its current level. However, a wide range of estimates exists, with high and low targets of $3.4995 and $2.6402, respectively, highlighting the market's uncertainty.
X.T.L. Biopharmaceuticals Ltd. ADR Stock (XTLB) Year by Year Forecast
X.T.L. Biopharmaceuticals Ltd. ADR Stock (XTLB) Price Forecast for 2024
Our forecast for XTLB stock price in 2024 now indicates an average price target of $2.8789 with a high forecast of $4.9897 and a low forecast of $0.7681. The average prediction reflects an increase of +9.05% from the last recorded price of $2.64.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| July, 2024 | $2.0508 | $2.0006 | $2.3808 | -22.32% |
| August, 2024 | $1.9311 | $1.931 | $2.261 | -26.85% |
| September, 2024 | $1.6614 | $1.6466 | $2.1883 | -37.07% |
| October, 2024 | $1.6158 | $1.5357 | $2.0515 | -38.79% |
| November, 2024 | $1.5458 | $1.422 | $1.8118 | -41.45% |
| December, 2024 | $1.4855 | $1.4423 | $1.6121 | -43.73% |
X.T.L. Biopharmaceuticals Ltd. ADR Stock (XTLB) Price Forecast for 2025
X.T.L. Biopharmaceuticals Ltd. ADR Stock (XTLB) is expected to reach an average price of $1.8871 in 2025, with a high prediction of $2.9259 and a low estimate of $0.8483. This indicates an -28.52% fall from the last recorded price of $2.64.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $1.5226 | $1.4226 | $1.8424 | -42.32% |
| February, 2025 | $1.5629 | $1.4827 | $2.0078 | -40.80% |
| March, 2025 | $1.0632 | $1.054 | $1.7731 | -59.73% |
| April, 2025 | $1.2836 | $0.8483 | $1.5436 | -51.38% |
| May, 2025 | $1.3538 | $1.2736 | $1.5838 | -48.72% |
| June, 2025 | $1.5641 | $1.344 | $1.6741 | -40.75% |
| July, 2025 | $1.8145 | $1.3942 | $2.3143 | -31.27% |
| August, 2025 | $1.6747 | $1.5946 | $1.8245 | -36.56% |
| September, 2025 | $1.975 | $1.6649 | $2.3246 | -25.19% |
| October, 2025 | $2.2954 | $1.8251 | $2.5753 | -13.05% |
| November, 2025 | $2.3756 | $1.9566 | $2.4946 | -10.01% |
| December, 2025 | $2.556 | $2.0957 | $2.9259 | -3.18% |
X.T.L. Biopharmaceuticals Ltd. ADR Stock (XTLB) Price Forecast for 2026
The predicted value for X.T.L. Biopharmaceuticals Ltd. ADR (XTLB) in 2026 is set at an average of $4.6924. Estimates vary from a peak of $6.9187 to a trough of $2.4661, indicating an +77.74% surge from the present price of $2.64.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $2.6358 | $2.4661 | $2.7663 | -0.16% |
| February, 2026 | $3.2565 | $2.4963 | $3.6265 | +23.35% |
| March, 2026 | $3.3368 | $3.2466 | $4.3967 | +26.39% |
| April, 2026 | $3.9772 | $2.9372 | $6.3372 | +50.65% |
| May, 2026 | $3.5575 | $3.3772 | $4.0372 | +34.75% |
| June, 2026 | $3.4377 | $3.1777 | $3.8176 | +30.22% |
| July, 2026 | $3.7585 | $3.3398 | $4.0378 | +42.37% |
| August, 2026 | $3.8184 | $3.4333 | $4.0284 | +44.63% |
| September, 2026 | $4.6787 | $3.5086 | $6.9187 | +77.22% |
| October, 2026 | $4.819 | $3.5688 | $5.429 | +82.54% |
| November, 2026 | $4.7193 | $4.3591 | $5.8792 | +78.76% |
| December, 2026 | $4.1696 | $4.0496 | $4.7893 | +57.94% |
X.T.L. Biopharmaceuticals Ltd. ADR Stock (XTLB) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for X.T.L. Biopharmaceuticals Ltd. ADR (XTLB) is $3.1961, with a high forecast of $4.8097 and a low forecast of $1.5825. This indicates an +21.06% increase from the last price of $2.64.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $4.1999 | $3.8298 | $4.8097 | +59.09% |
| February, 2027 | $3.4302 | $3.1901 | $4.19 | +29.93% |
| March, 2027 | $3.0005 | $2.7909 | $3.6802 | +13.66% |
| April, 2027 | $2.6708 | $2.4808 | $3.2307 | +1.17% |
| May, 2027 | $2.611 | $2.5012 | $2.8323 | -1.10% |
| June, 2027 | $2.4314 | $2.2814 | $2.7511 | -7.90% |
| July, 2027 | $2.4393 | $2.2915 | $2.8815 | -7.60% |
| August, 2027 | $2.332 | $2.072 | $2.7018 | -11.67% |
| September, 2027 | $1.9523 | $1.712 | $2.252 | -26.05% |
| October, 2027 | $1.7516 | $1.5825 | $2.0124 | -33.65% |
| November, 2027 | $1.9229 | $1.6827 | $2.0429 | -27.16% |
| December, 2027 | $1.8432 | $1.723 | $2.4531 | -30.18% |
X.T.L. Biopharmaceuticals Ltd. ADR Stock (XTLB) Price Forecast for 2028
In 2028, X.T.L. Biopharmaceuticals Ltd. ADR (XTLB) is projected to reach an average price of $1.0334, with a high projection of $1.8333 and a low estimate of $0.2335. This indicates an -60.86% fall from the last price of $2.64.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.2335 | $0.2335 | $1.8333 | -91.15% |
| February, 2028 | $1.4388 | $1.084 | $1.7036 | -45.50% |
| March, 2028 | $1.6241 | $1.3568 | $1.6941 | -38.48% |
| April, 2028 | $1.4598 | $1.4381 | $1.7342 | -44.70% |
| May, 2028 | $1.6248 | $1.2746 | $1.6248 | -38.46% |
| June, 2028 | $1.405 | $1.395 | $1.6349 | -46.78% |
| July, 2028 | $1.58 | $1.4251 | $1.6853 | -40.15% |
| August, 2028 | $1.4457 | $1.4056 | $1.6455 | -45.24% |
| September, 2028 | $1.4559 | $1.3657 | $1.7759 | -44.85% |
| October, 2028 | $1.5562 | $1.2961 | $1.6262 | -41.05% |
| November, 2028 | $1.5366 | $1.3666 | $1.5866 | -41.80% |
| December, 2028 | $1.2569 | $1.157 | $1.5766 | -52.39% |
X.T.L. Biopharmaceuticals Ltd. ADR Stock (XTLB) Price Forecast for 2029
The 2029 price forecast for X.T.L. Biopharmaceuticals Ltd. ADR Stock (XTLB) is $3.1083 on average, with a high prediction of $5.2295 and a low estimate of $0.987. This represents an +17.74% increase from the previous price of $2.64.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.0274 | $0.987 | $1.2769 | -61.08% |
| February, 2029 | $1.2111 | $0.9973 | $1.3274 | -54.12% |
| March, 2029 | $1.1354 | $1.0578 | $1.2877 | -56.99% |
| April, 2029 | $1.0581 | $1.0128 | $1.2528 | -59.92% |
| May, 2029 | $1.2484 | $0.9881 | $1.2684 | -52.71% |
| June, 2029 | $1.1787 | $1.1539 | $1.3686 | -55.35% |
| July, 2029 | $1.1099 | $0.9987 | $1.4089 | -57.96% |
| August, 2029 | $1.1093 | $1.0392 | $1.1612 | -57.98% |
| September, 2029 | $1.1396 | $1.0076 | $1.1893 | -56.83% |
| October, 2029 | $3.4999 | $1.0846 | $5.2295 | +32.57% |
| November, 2029 | $2.8302 | $2.5901 | $3.475 | +7.20% |
| December, 2029 | $2.5954 | $2.5903 | $2.9201 | -1.69% |
X.T.L. Biopharmaceuticals Ltd. ADR Stock (XTLB) Price Forecast for 2030
X.T.L. Biopharmaceuticals Ltd. ADR Stock (XTLB) is expected to reach an average price of $1.9211 in 2030, with a high forecast of $2.7706 and a low forecast of $1.0715. This signifies an -27.23% decrease from the last price of $2.64.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $2.441 | $2.3404 | $2.7706 | -7.54% |
| February, 2030 | $2.3915 | $2.2213 | $2.6015 | -9.41% |
| March, 2030 | $2.3421 | $2.152 | $2.482 | -11.28% |
| April, 2030 | $2.3355 | $2.0726 | $2.4095 | -11.53% |
| May, 2030 | $1.7573 | $1.7573 | $2.2731 | -33.43% |
| June, 2030 | $1.7559 | $1.6939 | $2.0336 | -33.49% |
| July, 2030 | $1.7078 | $1.644 | $1.8342 | -35.31% |
| August, 2030 | $1.7252 | $1.6677 | $2.0649 | -34.65% |
| September, 2030 | $1.9457 | $1.6453 | $2.2306 | -26.30% |
| October, 2030 | $1.2864 | $1.2772 | $1.9961 | -51.27% |
| November, 2030 | $1.4428 | $1.0715 | $1.6468 | -45.35% |
| December, 2030 | $1.6475 | $1.3622 | $1.8075 | -37.59% |
0.79%
3.50%
Cap:
|
Volume (24h):